Sign in

CIK 0001781983

  • Non-accelerated filer
  • Smaller reporting company

Aprea Therapeutics, Inc.

Sign in to watch
Ticker
APRE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 215-948-4119
Business address
3805 OLD EASTON ROAD, DOYLESTOWN, PA, 18902
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-06-16 Peters Richard Director Grant or award +3,135 6,254
2026-06-16 Peters Richard Director Grant or award · Stock Options (Right to Buy) +12,555 12,555
2026-03-31 Peters Richard Director Purchase · Pre-Funded Warrant +123,915 $0.81 $100K 123,915
2026-03-31 Peters Richard Director Purchase · Common Warrant +123,915 123,915
2025-06-05 Peters Richard Director Grant or award +1,045 3,119
2025-06-05 Peters Richard Director Grant or award · Stock Options (Right to Buy) +4,185 4,185
2024-06-20 Peters Richard Director Grant or award +1,045 2,074
2024-06-20 Peters Richard Director Grant or award · Stock Options (Right to Buy) +4,185 4,185
2023-08-23 Peters Richard Director Grant or award +500 1,029
2023-08-23 Peters Richard Director Grant or award · Stock Options (Right to Buy) +2,000 2,000
2022-07-28 Peters Richard Director Grant or award +5,995 10,605
2022-07-28 Peters Richard Director Grant or award · Stock Option (right to Buy) +29,575 29,575
2021-06-30 Peters Richard Director Grant or award +4,610 4,610
2021-06-30 Peters Richard Director Grant or award · Stock Option (Right to Buy) +22,750 22,750
2020-06-26 Peters Richard Director Grant or award · Stock Option (right to Buy) +7,000 7,000

Page 1 of 1 · 15 trades